help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brooks-Worrell, B. M.
Right arrow Articles by Pihoker, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brooks-Worrell, B. M.
Right arrow Articles by Pihoker, C.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 5 2222-2227
Copyright © 2004 by The Endocrine Society

Autoimmunity to Islet Proteins in Children Diagnosed with New-Onset Diabetes

Barbara M. Brooks-Worrell, Carla J. Greenbaum, Jerry P. Palmer and Catherine Pihoker

Departments of Medicine (B.M.B.-W., J.P.P.) and Pediatrics (C.P.), University of Washington, Seattle, Washington 98195; Department of Medicine (B.M.B.-W., J.P.P.), Department of Veterans Affairs Puget Sound Health Care System, Seattle, Washington 98108; Benaroya Research Institute at Virginia Mason (C.J.G.); and Children’s Hospital and Regional Medical Center (C.P.), Seattle, Washington 98105

Address all correspondence and requests for reprints to: Barbara Brooks-Worrell, Ph.D., 1660 South Columbian Way (111), DVA Puget Sound Health Care System, Seattle, Washington 98108. E-mail: bbrooks{at}u.washington.edu.

Autoantibody and T cells reacting with islet proteins have been demonstrated in patients with type 1 diabetes. In recent years an increasing number of children have been clinically classified with type 2 (not ketosis prone, evidence of insulin resistance, presence of acanthosis nigricans, and obesity) or indeterminant diabetes (admixture of clinical features of types 1 and 2). In this study, we compared the islet cell autoantibody and T-cell responses to islet proteins in type 2 (n = 19) and indeterminant (n = 16) children (<18 yr of age) to classic type 1 (n = 37) diabetic patients. We observed that 37 of 37 type 1 diabetic children demonstrated autoantibody and/or T-cell reactivity to islet proteins. Fourteen of the 19 type 2 patients were positive for islet cell autoantibodies, and six of 14 were positive for T-cell responses to islet proteins. For the indeterminant patients, 11 of 16 of the patients were positive for autoantibodies, and six of 16 patients were positive for T-cell responses to islet proteins. These results demonstrate that autoimmunity to islet proteins is present in a high percentage of children classified as indeterminant or type 2 diabetes. Moreover, the presence of obesity or acanthosis nigracans does not reliably distinguish children with or without islet cell autoimmunity.

This work was supported in part by the Medical Research Service of the Department of Veterans Affairs through a VA Merit Review grant and by the following grants from the NIH: MO1 RR00037-41, P01 DK53004, and P30 DK17047.

Abbreviations: DKA, Diabetic ketoacidosis; GAD65Ab, glutamic acid decarboxylase 65-kDa autoantibody; HLA, human leukocyte antigen; IA-2, insulinoma associated protein-2 autoantibody; IAA, insulin autoantibody; ICA, islet cell antibody; PBMC, peripheral blood mononuclear cell; SI, stimulation index.




This article has been cited by other articles:


Home page
DiabetesHome page
D. M. Harlan, N. S. Kenyon, O. Korsgren, B. O. Roep, and for the Immunology of Diabetes Society
Current Advances and Travails in Islet Transplantation
Diabetes, October 1, 2009; 58(10): 2175 - 2184.
[Full Text] [PDF]


Home page
DiabetesHome page
H. Tfayli, F. Bacha, N. Gungor, and S. Arslanian
Phenotypic Type 2 Diabetes in Obese Youth: Insulin Sensitivity and Secretion in Islet Cell Antibody-Negative Versus -Positive Patients
Diabetes, March 1, 2009; 58(3): 738 - 744.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. Dabelea, J. DeGroat, C. Sorrelman, M. Glass, C. A. Percy, C. Avery, D. Hu, R. B. D'Agostino Jr., J. Beyer, G. Imperatore, et al.
Diabetes in Navajo Youth: Prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study
Diabetes Care, March 1, 2009; 32(Supplement_2): S141 - S147.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
The Writing Group for the SEARCH for Diabetes in Y
Incidence of Diabetes in Youth in the United States
JAMA, June 27, 2007; 297(24): 2716 - 2724.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
T J Wilkin
The great weight gain experiment, accelerators, and their implications for autoantibodies in diabetes
Arch. Dis. Child., June 1, 2006; 91(6): 456 - 458.
[Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
T Reinehr, E Schober, S Wiegand, A Thon, R Holl, and on behalf of the DPV-Wiss Study Group
{beta}-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification?
Arch. Dis. Child., June 1, 2006; 91(6): 473 - 477.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Pihoker, L. K. Gilliam, C. S. Hampe, and A. Lernmark
Autoantibodies in Diabetes
Diabetes, December 1, 2005; 54(suppl_2): S52 - S61.
[Abstract] [Full Text] [PDF]


Home page
Clin. DiabetesHome page
K. C. Copeland, D. Becker, M. Gottschalk, and D. Hale
Type 2 Diabetes in Children and Adolescents: Risk Factors, Diagnosis, and Treatment
Clin. Diabetes, October 1, 2005; 23(4): 181 - 185.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society